Skip to content
Tevard Biosciences logo — Pioneering tRNA therapeutics to modulate mRNA function and c...

Tevard Biosciences

Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.

Founded 2017 United States Cambridge, United States 27 employees Biotechnology, Health and Wellness

General Information

Company Name Tevard Biosciences
Founded Year 2017
Location United States Cambridge, United States
Employees 27
Industries Biotechnology, Health and Wellness
Social

BounceWatch is an independent company data service, not affiliated with Tevard Biosciences. To contact Tevard Biosciences, visit tevard.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tevard Biosciences compare?

A PDF of Tevard Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tevard Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tevard Biosciences

Tevard Biosciences is a biotechnology startup that is pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Since its founding in 2017, the company has been focused on leveraging this innovative approach to make significant advancements in the fields of biotechnology and health and wellness. Tevard Biosciences has the potential to revolutionize the treatment of genetic diseases, offering a promising solution to addressing a wide spectrum of medical conditions. As the company continues to make strides in its research and development efforts, it presents an intriguing opportunity for venture capital firms looking to invest in cutting-edge biotech innovations. With the potential to make a profound impact on the healthcare industry, Tevard Biosciences is a compelling prospect for investors seeking to support groundbreaking advancements in genetic therapeutics.

Business keywords: tRNA therapeutics, mRNA modulation, Genetic diseases, Gene therapy, Rare diseases, AAV, Therapeutics, Genetic medicine, Biomedical innovation

No funding data available for Tevard Biosciences yet.

Tevard Biosciences Alternatives & Competitors

View All Alternatives
Tevard Biosciences vs

On-target gene therapies

Seed
15 employees
Biotechnology, Health and Wellness
Tevard Biosciences vs

Reimagine the Power of RNA

Venture round
13 employees
Biotechnology, Health Care
Tevard Biosciences vs
Alltrna
Alltrna United States

The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeutic potent...

Series B
49 employees
Biotechnology, Health Care

FAQ About Tevard Biosciences

Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.
Tevard Biosciences was founded in 2017.
Tevard Biosciences is headquartered in Cambridge, United States.
Tevard Biosciences operates in Biotechnology and Health and Wellness. Its work centres on tRNA therapeutics, mRNA modulation, Genetic diseases and Gene therapy.
Tevard Biosciences has approximately 27 employees.
Top alternatives and competitors to Tevard Biosciences include Alia Therapeutics, Elixirgen Therapeutics, Inc., Alltrna, Capstan Therapeutics, Tessera Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tevard Biosciences and Alia Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tevard Biosciences, https://bouncewatch.com/company/tevard-biosciences, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout